Of the 146 FFPE HGSC tumour specimens tested, 41 (28%) carried a Tier I/II variant in either BRCA1 or BRCA2 (n = 36), or BRCA1/2 plus a second variant (n = 5). The gene discussed is BRCA1; the disease is neoplasm.